Justis P. Ehlers, MD

216.444.2020

Justis P. Ehlers, MD

Appointed: 2010

Justis P. Ehlers, MD
Department: Ophthalmology
Location: Cleveland Clinic Main Campus
Mail Code i32
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2020
WorkFax:216.445.2226
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Justis P. Ehlers, MD, is a Staff physician on the vitreoretinal service of the Cole Eye Institute in the Department of Ophthalmology at Cleveland Clinic. He was appointed in 2010. Dr. Ehlers received his undergraduate degree summa cum laude at the University of Notre Dame. He completed his medical degree at the Washington University School of Medicine in St. Louis, Missouri. Following medical school, he did an internship at St. Luke’s Hospital in Chesterfield, Missouri. He completed his ophthalmology residency at the Wills Eye Institute in Philadelphia, Pennsylvania and served as Chief Resident from 2004-2005. From the Wills Eye Institute, Dr. Ehlers then completed a vitreoretinal surgery and disease fellowship at the Duke Eye Institute in Durham, North Carolina.

Clinically, Dr. Ehlers specializes in the diagnosis and management of medical and surgical vitreoretinal diseases including: age-related macular degeneration (ARMD), retinal vascular occlusive disease, diabetic retinopathy, retinal detachment, myopic degeneration, cystoid macular edema, ocular trauma, epiretinal membranes, vitreomacular traction syndrome, and macular holes.

Active in research, Dr. Ehlers has participated as a co-investigator on numerous clinical trials including studies on macular degeneration, vitreoretinal interface abnormalities, retinal venous occlusive disease, and ophthalmic imaging.

Dr. Ehlers has a particular interest in advanced vitreoretinal imaging, including intraoperative optical coherence tomography (OCT). OCT is a non-contact imaging modality that provides high resolution cross-sectional and three-dimensional information of tissue architecture and microstructure. While working with Dr. Cynthia Toth at Duke University, Dr. Ehlers tested and optimized a prototype operating microscope integrated OCT system allowing for real-time OCT-based visualization of intraocular maneuvers. Intraoperative OCT allows for direct feedback of the surgeon regarding the impact of surgical maneuvers and the need or lack of need for additional intervention. Complementing the use of intraoperative OCT, Dr. Ehlers is currently developing novel OCT-friendly surgical instrumentation. Dr. Ehlers is a major contributor to the medical literature having authored more than 50 original reports, book chapters, electronic publications, and scientific abstracts. Additionally, Dr. Ehlers was the co-chief editor of the Wills Eye Manual, 5th Edition, one of the best-selling texts in ophthalmology. He currently serves as a scientific reviewer for numerous ophthalmic journals and has served as an associate editor of the journal, Retina. Dr. Ehlers serves on the American Academy of Ophthalmology COMPASS Retina Subspecialty committee and previously served as an American Academy of Ophthalmology congressional advocacy ambassador.

Professional Highlights

  • Co-chief Editor, Wills Eye Manual, 5th edition.
  • Heed Fellow and Ronald G. Michels Fellow, Duke Eye Center
  • Chief Resident, Wills Eye Institute
  • Associate Editor, Retina, 2009-2010.

Education & Fellowships

Fellowship - Duke University Medical Center
Vitreoretinal Surgery
Durham, NC USA
2010
Residency - Wills Eye Hospital
Ophthalmology
Philadelphia, PA USA
2008
Internship - Saint Luke's Hospital
Preliminary Medicine
Chesterfield, MO USA
2005
Medical School - Washington University School of Medicine
St. Louis, MO USA
2004
Undergraduate - University of Notre Dame
Notre Dame, IN USA
2000

Certifications

  • Ophthalmology

Specialty Interests

Diabetic retinopathy, macular degeneration, retinal detachment, retinal vein occlusions, macular holes, macular puckers and epiretinal membranes, eye injuries and ocular trauma, myopic degeneration, retinal artery occlusions, cystoid macular edema, histoplasmosis, choroidal neovascularization, retinal neovascularization, and other vitreoretinal diseases. Advanced vitreoretinal imaging, with particular interest in optical coherence tomography (OCT) and utilizing OCT in the operating room to improve our understanding of vitreoretinal surgical diseases and the ultrastructural impact of surgical maneuvers, to help guide surgical interventions and improve outcomes.

Awards & Honors

  • Ronald G. Michels Fellowship Award, 2009
  • Heed Fellowship Award, 2008
  • Shipman Award, 2008
  • Alpha Omega Alpha, 2003
  • Senior Merit Scholar, 2003
  • Phi Beta Kappa, 2000

Innovations & Patents

  • Furthering the progress of the use of intraoperative optical coherence tomography (OCT) for the study of vitreoretinal surgical diseases and the impact of surgical manipulations on microstructural anatomy, such as with optic-pit related maculopathy.
  • Development of the use of OCT contrast agents for enhanced visualization of tissue interfaces for ophthalmic applications of OCT imaging, including the development of “functional OCT” for incisional integrity assessment.
  • Optimization and testing of OCT integration into the surgical microscope, allowing for real-time visualization of surgical maneuvers, characterization of intraocular instrumentations, and optimization of capturing OCT-visualized intraoperative motion.

Memberships

  • American Society of Retina Specialists, 2008- present
  • Society of Heed Fellows, 2008- present
  • Wills Eye Hospital Society, 2008 - present
  • Association for Research in Vision and Ophthalmology, 2006 - present
  • American Academy of Ophthalmology, 2005 - present
  • American Medical Association, 2003 - present

Treatment & Services

  • Vitreoretinal Surgery

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/30/2013, Dr. Ehlers has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Ehlers received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • ThromboGenics NV

Royalty Payments. Dr. Ehlers receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • Bioptigen, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site